Abiomed, Inc.
ABMD · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,146,086 | $11,280,268 | $15,079,370 | $16,345,108 |
| - Cash | $182,335 | $180,492 | $132,818 | $144,255 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $10,963,751 | $11,099,776 | $14,946,552 | $16,200,853 |
| Revenue | $265,921 | $277,149 | $269,850 | $261,176 |
| % Growth | -4.1% | 2.7% | 3.3% | – |
| Gross Profit | $217,041 | $224,523 | $218,393 | $213,549 |
| % Margin | 81.6% | 81% | 80.9% | 81.8% |
| EBITDA | $226,136 | $80,214 | $91,811 | $71,593 |
| % Margin | 85% | 28.9% | 34% | 27.4% |
| Net Income | $106,133 | $54,554 | $60,325 | $45,752 |
| % Margin | 39.9% | 19.7% | 22.4% | 17.5% |
| EPS Diluted | 2.32 | 1.19 | 1.31 | 1 |
| % Growth | 95% | -9.2% | 31% | – |
| Operating Cash Flow | $13,421 | $68,103 | $78,972 | $90,487 |
| Capital Expenditures | -$5,609 | -$6,783 | -$14,891 | -$6,478 |
| Free Cash Flow | $7,812 | $61,320 | $64,081 | $84,009 |